Benefit-Risk Balance Of Multiple Myeloma Treatment Revlimid Remains Positive
9/26/2011
According to confirmation from the European Medicines Agency the benefit-risk balance for Revlimid (lenalidomide) remains positive within its approved patient population, however, doctors are advised of the risk of new cancers as a result of treatment with the medicine...
A study published in the September 20 issue of the online open-access journal PLoS Biology reveals that researchers discovered, during their study of ovarian cancer, that a substantial number of ovarian tumors show a gene that is closely related to the estrogen receptor. The gene is broken and fused to an adjacent gene by a chromosome rearrangement...
International Clinical Trial Finds Abiraterone Acetate Improves Fatigue In Prostate Cancer Patients
9/26/2011
Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, according to results from a phase III clinical trial...
Sexual Intimacy After Prostate Treatment Improves With Couples Counseling
9/26/2011
Prostate cancer survivors and their partners experience improved sexual satisfaction and function after couples counseling, according to research at The University of Texas MD Anderson Cancer Center...
Risk Of A Rare Lung Cancer May Be Increased By Exposure To Goats
9/26/2011
Exposure to goats could increase the risk of a certain type of lung cancer, according to French researchers. The study, which was presented at the European Respiratory Society's Annual Congress in Amsterdam , has linked a professional exposure to goats with a distinct subset of lung cancer, known as pneumonic-type lung adenocarcinoma (P-ADC)...
Unnecessary Surgery Could Be Prevented By New Diagnostic Imaging For Lung Cancer
9/26/2011
A new type of diagnostic imaging - which can better differentiate benign lung lesions from those which are cancerous - could be used to prevent unnecessary surgery by enabling more accurate diagnosis of the disease...
UN Discussions Focus On Non-Communicable Diseases
9/26/2011
The European Chronic Disease Alliance (ECDA)1 welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers. "It is a memorable day in the history of public health...
Zoledronic Acid Reduces The Recurrence Of Breast Cancer In Post-Menopausal Women
9/26/2011
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress [1]. Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care...
Regular Biopsies Needed To Ensure Correct Treatment In Breast Cancer Patients Who Relapse
9/26/2011
New research has found that breast cancer tumours change their hormonal status throughout the course of disease, whereas the decision about the most effective treatment for the patient is usually only based on one biopsy of the primary tumour...
Breast Cancer Relapse Prevented For Up To 8 Years By Aromatase Inhibitor Letrozole
9/26/2011
Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer...